Di Nuzzo Private Wealth, Inc. Halozyme Therapeutics, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $617 Million
- Q1 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 15 shares of HALO stock, worth $808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 13
15.38%
Holding current value
$808
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$950 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$692 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$326 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$210 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$198 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.51B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...